drugset / Trial / NCT01535950
Safety and Efficacy of Intravitreal LFG316 in Wet Age Related Macular Degeneration (AMD)
RandomizedParallel-groupSingle-blindTreatment
Summary
This study will assess the safety and efficacy of LFG316 in patients with age related macular degeneration.
Timeline
- Start
- 2012-02
- Primary completion
- 2013-07
- Completion
- 2013-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | tesidolumab | Monoclonal antibody | — | Intravitreal |